Protein shedding in urothelial bladder cancer: prognostic implications of soluble urinary EGFR and EpCAM

BACKGROUND: Better biomarkers must be found to develop clinically useful urine tests for bladder cancer. Proteomics can be used to identify the proteins released by cancer cell lines and generate candidate markers for developing such tests. METHODS: We used shotgun proteomics to identify proteins re...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Br J Cancer
Egile Nagusiak: Bryan, R T, Regan, H L, Pirrie, S J, Devall, A J, Cheng, K K, Zeegers, M P, James, N D, Knowles, M A, Ward, D G
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2015
Gaiak:
Molecular Diagnostics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4366887/
https://ncbi.nlm.nih.gov/pubmed/25719831
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2015.21
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak